585 related articles for article (PubMed ID: 26825555)
21. Molecule specific effects of PKA-mediated phosphorylation on rat isolated heart and cardiac myofibrillar function.
Hanft LM; Cornell TD; McDonald CA; Rovetto MJ; Emter CA; McDonald KS
Arch Biochem Biophys; 2016 Jul; 601():22-31. PubMed ID: 26854722
[TBL] [Abstract][Full Text] [Related]
22. Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I.
Layland J; Cave AC; Warren C; Grieve DJ; Sparks E; Kentish JC; Solaro RJ; Shah AM
FASEB J; 2005 Jul; 19(9):1137-9. PubMed ID: 15855227
[TBL] [Abstract][Full Text] [Related]
23. Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing.
Konhilas JP; Irving TC; Wolska BM; Jweied EE; Martin AF; Solaro RJ; de Tombe PP
J Physiol; 2003 Mar; 547(Pt 3):951-61. PubMed ID: 12562915
[TBL] [Abstract][Full Text] [Related]
24. Ouabain worsens diastolic sarcomere length in myocytes from a cardiomyopathy mouse model.
Düsener S; Flenner F; Maack C; Kohlhaas M; Bay J; Carrier L; Friedrich FW
Eur J Pharmacol; 2021 Aug; 904():174170. PubMed ID: 33984298
[TBL] [Abstract][Full Text] [Related]
25. Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca
Sparrow AJ; Watkins H; Daniels MJ; Redwood C; Robinson P
Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H715-H722. PubMed ID: 32083971
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium.
Pi Y; Zhang D; Kemnitz KR; Wang H; Walker JW
J Physiol; 2003 Nov; 552(Pt 3):845-57. PubMed ID: 12923217
[TBL] [Abstract][Full Text] [Related]
27. Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction.
van Dijk SJ; Dooijes D; dos Remedios C; Michels M; Lamers JM; Winegrad S; Schlossarek S; Carrier L; ten Cate FJ; Stienen GJ; van der Velden J
Circulation; 2009 Mar; 119(11):1473-83. PubMed ID: 19273718
[TBL] [Abstract][Full Text] [Related]
28. Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes.
Ramachandra CJA; Kp MMJ; Chua J; Hernandez-Resendiz S; Liehn EA; Knöll R; Gan LM; Michaëlsson E; Jonsson MKB; Ryden-Markinhuhta K; Bhat RV; Fritsche-Danielson R; Lin YH; Sadayappan S; Tang HC; Wong P; Shim W; Hausenloy DJ
Cardiovasc Res; 2022 Jan; 118(2):517-530. PubMed ID: 33705529
[TBL] [Abstract][Full Text] [Related]
29. Basal and β-adrenergic regulation of the cardiac calcium channel CaV1.2 requires phosphorylation of serine 1700.
Fu Y; Westenbroek RE; Scheuer T; Catterall WA
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16598-603. PubMed ID: 25368181
[TBL] [Abstract][Full Text] [Related]
30. In Vivo Analysis of Troponin C Knock-In (A8V) Mice: Evidence that TNNC1 Is a Hypertrophic Cardiomyopathy Susceptibility Gene.
Martins AS; Parvatiyar MS; Feng HZ; Bos JM; Gonzalez-Martinez D; Vukmirovic M; Turna RS; Sanchez-Gonzalez MA; Badger CD; Zorio DAR; Singh RK; Wang Y; Jin JP; Ackerman MJ; Pinto JR
Circ Cardiovasc Genet; 2015 Oct; 8(5):653-664. PubMed ID: 26304555
[TBL] [Abstract][Full Text] [Related]
31. Enhanced N-terminal degradation of troponin I blunts cardiac function responsiveness to isoproterenol in 4-week tail-suspended rats.
Zhang L; Song Z; Chang H; Wang YY; Yu ZB
Mol Med Rep; 2013 Jan; 7(1):271-9. PubMed ID: 23042367
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the effects of a truncating and a missense MYBPC3 mutation on contractile parameters of engineered heart tissue.
Wijnker PJ; Friedrich FW; Dutsch A; Reischmann S; Eder A; Mannhardt I; Mearini G; Eschenhagen T; van der Velden J; Carrier L
J Mol Cell Cardiol; 2016 Aug; 97():82-92. PubMed ID: 27108529
[TBL] [Abstract][Full Text] [Related]
34. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
Duncker DJ; Boontje NM; Merkus D; Versteilen A; Krysiak J; Mearini G; El-Armouche A; de Beer VJ; Lamers JM; Carrier L; Walker LA; Linke WA; Stienen GJ; van der Velden J
Circ Heart Fail; 2009 May; 2(3):233-42. PubMed ID: 19808345
[TBL] [Abstract][Full Text] [Related]
35. Cardiac function is regulated by B56α-mediated targeting of protein phosphatase 2A (PP2A) to contractile relevant substrates.
Kirchhefer U; Brekle C; Eskandar J; Isensee G; Kučerová D; Müller FU; Pinet F; Schulte JS; Seidl MD; Boknik P
J Biol Chem; 2014 Dec; 289(49):33862-73. PubMed ID: 25320082
[TBL] [Abstract][Full Text] [Related]
36. N-terminal phosphorylation of cardiac troponin-I reduces length-dependent calcium sensitivity of contraction in cardiac muscle.
Rao VS; Korte FS; Razumova MV; Feest ER; Hsu H; Irving TC; Regnier M; Martyn DA
J Physiol; 2013 Jan; 591(2):475-90. PubMed ID: 23129792
[TBL] [Abstract][Full Text] [Related]
37. Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites.
Takimoto E; Soergel DG; Janssen PM; Stull LB; Kass DA; Murphy AM
Circ Res; 2004 Mar; 94(4):496-504. PubMed ID: 14726477
[TBL] [Abstract][Full Text] [Related]
38. The contributions of cardiac myosin binding protein C and troponin I phosphorylation to β-adrenergic enhancement of in vivo cardiac function.
Gresham KS; Stelzer JE
J Physiol; 2016 Feb; 594(3):669-86. PubMed ID: 26635197
[TBL] [Abstract][Full Text] [Related]
39. Essential role of troponin I in the positive inotropic response to isoprenaline in mouse hearts contracting auxotonically.
Layland J; Grieve DJ; Cave AC; Sparks E; Solaro RJ; Shah AM
J Physiol; 2004 May; 556(Pt 3):835-47. PubMed ID: 14966306
[TBL] [Abstract][Full Text] [Related]
40. Effects of contractile protein phosphorylation on force development in permeabilized rat cardiac myocytes.
Verduyn SC; Zaremba R; van der Velden J; Stienen GJ
Basic Res Cardiol; 2007 Nov; 102(6):476-87. PubMed ID: 17546528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
